5[3]Kauschke SG,Knoor A,Heke M,et al.Two assays for measuring fibrosis:reversetranscriptase-polymerase chain reaction of collagen alpha(1)(Ⅲ)mRNA is an early predictor of subsequent collange deposition while a novel serum N-terminal procollagen(Ⅲ)propeptide assay reflects manifest fibrosis in carbom tetrachloride-treated rats[J].Anal Biochem,1999,275(2):131-140.
6[4]Walsh KM,Fletcher A,MacSween RN,et al.Comparison of assays for N-terminalpropeptide of type Ⅲ procollagen in chronic hepatitis C by using receiver operating charateristic analysis[J].Eur J Gastroenterol Hepatol,1999,11(8):827-831.
7[5]Zachariae H,Heichendorff L,Sogaard H.The value of aminoterminal propeptide of type Ⅲ procollagen in routine screening for methotrexate-induced liver fibrosis:a 10-year follow-up[J].Br J Dermatol,2001,144(1):100-103.
8[6]Serejo F,Costa A,Olivera AG,et al.Alpha-interferon improves liver fibrosisin chronic hepatitis C:clinical significance of the serum N-terminal propetide of procollagen type Ⅲ[J].Dig Dis Sci,2001,46(8):1684-1689.
9[7]Yi Qiu,Yujin Hoshida,Naoya Kato,et al.A simple combination of serum typecollagen Ⅳ and prothrombin time to diagnose cirrhosis in patients with chronic active hepatitis[J].Hepatol Res,2004,30(4):214-220.
10[9]Walsh KM,Fletcher A,Macsween RN,et al.Basement membrane peptides as markersof liver disease in chronic hepatitis C[J].J Hepatol,2000,32(2):325-330.
